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Sex Med 2Introduction: Water channel aquaporin 3 (AQP3) is an aquaglyceroporin that transports small neutral solutes
and water. All-trans retinoic acid (ATRA), a member of the retinoid drug class, acts as a regulator in several
biological processes.
Aim: To investigate the effect of ATRA on the expression of AQP3 in human vaginal epithelial cells.
Methods: Human vaginal mucosal epithelial cells (CRL2616) were treated with ATRA 0, 0.01, 0.1, and 1 mmol/L
for 24 hours to examine the dose-dependent effects of ATRA andwith ATRA1mmol/L for 0, 3, 6, 12, and 24 hours.
Main Outcome Measures: The expression of AQP3 and retinoic acid receptor (RAR) was determined by
western blot analysis and reverse transcription polymerase chain reaction.
Results: AQP3 was detected in the cell membrane of human vaginal epithelial cells. ATRA increased the protein
expression and mRNA levels of AQP3 in a dose-dependent manner (P < .05). ATRA also increased the protein
expression of RARa (P < .05). Treatment of CRL2616 cells with an RAR antagonist (Ro 41-5253) signiﬁcantly
decreased AQP3 protein expression (P < .05).
Conclusion: ATRA mediated by RARa increased AQP3 gene and protein expression in human vaginal mucosal
epithelial cells. These results imply that AQP3 regulated by ATRA could play an important role in the mech-
anism of vaginal lubrication.
Sex Med 2016;4:e249ee254. Copyright  2016, The Authors. Published by Elsevier Inc. on behalf of the Inter-
national Society for Sexual Medicine. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Female sexual dysfunction is a common problem in women.
Laumann et al1 reported that 43% of women experience sexual
problems that negatively affect their quality of life. The physio-
logic mechanisms of genital sexual arousal are not clearly un-
derstood. The female sexual arousal response has been suggested
to be a complex physiologic process featuring clitoral and vaginalbruary 29, 2016. Accepted July 4, 2016.
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016;4:e249ee254engorgement and vaginal lubrication as a result of increased
clitoral and vaginal blood ﬂow.2e4 Vaginal lubrication is one
indicator of the genital sexual arousal response. However, the
underlying mechanisms of vaginal lubrication are not clear. The
vaginal mucosa includes a complex network of small capillaries
just beneath the vaginal epithelium that could account for
vaginal ﬂuid secretion and lubrication.5
Aquaporins (AQPs) are traditionally known as membrane
proteins that facilitate water movement across cells.6 In some
cases, AQPs can transport small solutes such as glycerol, ions,
and gas. Among the AQP family members, AQP3 transports
glycerol and presumably other small solutes across cells.7,8
Vaginal ﬂuid consists of various elements besides water, and
we previously reported the distinct localization of AQPs in the
vagina of rats and humans as a potential component of vaginal
lubrication.9,10 Thus, we targeted AQP3 as a potential active
mediator of vaginal lubrication.
All-trans retinoic acid (ATRA) is an important mediator of
several biological processes in the body, such as differentiation,
proliferation, embryogenesis, reproduction, and apoptosis, ande249
e250 Lee et alimmune-mediated anti-inﬂammatory effects.11e13 Retinoic acid
(RA) is reported to be an active regulator of body ﬂuid secretion,
and RA might be involved in maintaining the homeostasis of
bronchial surface ﬂuid secretion.14e16 We hypothesized that
ATRA and AQP3 might be involved in vaginal ﬂuid regulation.
In support of this hypothesis, ATRA was reported to increase the
expression of AQP3 and enhance biological activity in human
skin.17 In that study, topical application of ATRA induced a
meaningful response of epidermal AQP3 and strong immuno-
reactivity in the epidermal basal layers, suggesting possible
involvement of ATRA in the regulation of AQP3.AIMS
In the present study, we investigated whether ATRA regulates
AQP3 in human vaginal epithelial cells to assess the functional
implications of AQP3 in vaginal lubrication.METHODS
Cell Culture and Treatment
Human vaginal mucosal epithelial (CRL-2616) cells were ob-
tained from the American Type Culture Collection (Rockville,
MD, USA). Cells were incubated at 37C in 5% CO2 and
maintained in keratinocyte serum-free medium (Gibco BRL,
Paisley, UK). Cells were used when they reached a conﬂuent state.
ATRA was obtained from Sigma (St Louis, MO, USA). For
the in vitro studies, stock solutions of ATRA were prepared in
dimethyl sulfoxide and subsequent dilutions were prepared in
culture medium, so that the ﬁnal concentration of dimethyl
sulfoxide was always 0.1%. ATRA at concentrations of 0, 0.01,
0.1, and 1 mmol/L was applied to CRL2616 cells for 24 hours.
The RA receptor-a (RARa) antagonist, Ro41-5253, was pur-
chased from Sigma. Cells were allowed to attach for 24 hours and
then were incubated in medium with the appropriate concen-
tration of Ro 41-5253 (0.1e5 mmol/L).Immunocytochemistry
Cells were rinsed in phosphate buffered saline and then treated
with normal chicken serum for 30 minutes to block non-speciﬁc
binding. After washing in phosphate buffered saline, cells were
incubated with antibodies for AQP3 (1:100; Abcam, Cambridge,
MA, USA) in phosphate buffered saline for 12 to 14 hours at
4C. Immunoreactivity for AQP3 was detected using Alexa
Fluor 594-conjugated chicken anti-rabbit immunoglobulin G
(H þ L; Molecular Probes, Inc, Eugene, OR, USA). Cells were
mounted in a mounting solution containing 40-6-diamidino-2-
phenylindole. Cells were examined with an LSM 510 (Carl
Zeiss, Seoul, Korea) confocal microscope with an excitation
wavelength appropriate for the Alexa Fluor dyes (405 and
594 nm). Final images were constructed using LSM Image
Examiner software.Sodium Dodecylsulfate Polyacrylamide Gel
Electrophoresis and Western Blot
Proteins were electrophoresed on sodium dodecylsulfate 10%
polyacrylamide gels and transferred to a polyvinylidene diﬂuoride
membrane (Amersham Pharmacia Biotech, Little Chalfont, UK).
The blots were washed with Tris-buffered saline and Tween-20
(Tris-HCl 10 mmol/L, pH 7.6, NaCl 150 mmol/L, 0.05%
Tween-20). The membrane was blocked with 5% skimmed milk
for 1 hour and incubated with the appropriate primary antibody
at the dilution recommended by the supplier. Rabbit a-AQP3
(1:1,000; Calbiochem, Nottingham, UK), rabbit a-RARa
(1:1,000; Santa Cruz Biotechnology, Santa Cruz, CA, USA), and
glyceraldehyde 3-phosphate dehydrogenase (1:10,000; Cell
Signaling, Danvers, MA, USA) were used. The membrane was
washed, and the primary antibodies were detected with goat anti-
rabbit immunoglobulin G conjugated to horseradish peroxidase.
Antibody incubations were performed at 4C in an incubator.
Bands were visualized using enhanced chemiluminescence
(Amersham Pharmacia Biotech).Reverse Transcription Polymerase Chain Reaction
Total RNA from CRL2616 pellets was extracted by the acid
guanidium-thiocyanate-phenol-chloroform method using Tri-
Reagent. The concentration of total RNA was determined by
measuring the optical density at 260 nm. One microgram of total
RNA was converted into ﬁrst-strand cDNA using the ImProm-II
Reverse Transcription system with Oligo(dT)15 primers, as
suggested by the manufacturer’s instructions (Promega, Madi-
son, WI, USA). For the semiquantitative polymerase chain re-
action experiment, the reverse transcription product was
ampliﬁed using speciﬁc primers designed from human AQP3
cDNAs and b-actin cDNA. Ampliﬁed polymerase chain reaction
products were subjected to electrophoresis on 1.5% agarose gels
and visualized on an ultraviolet table.
The AQP3 forward and reverse primers were 50-ACCTTT
GCCATGTGCTTCCT-30 and 50-GCGTCTGTGCCAGGGT
GTA-30, respectively, and the b-actin forward and reverse
primers were 50-CTGGCACCCAGCACAATG-30 and 50-GCC
GATCCACACGGAGTACT-30.Data Analysis
Data were expressed as mean ± SD of the mean. The signif-
icance of differences among the groups was determined using
analysis of variance with post hoc Tukey test. Statistical signiﬁ-
cance was set at a P value less than 0.05.RESULTS
AQP3 Is Expressed in CRL2616 Cells
AQP3 was expressed in the cell membrane of human vaginal
mucosal epithelial cells (Figure 1A).Sex Med 2016;4:e249ee254
Figure 1. Effect of all-trans retinoic acid on the expression of AQP3 protein in cultured human vaginal mucosal epithelial cells. Panel A
shows the detection of AQP3 in the cell membrane of human vaginal epithelial cells (green) by confocal microscopy after immunostaining
with anti-AQP3. Cells also were stained with 40-6-diamidino-2-phenylindole to visualize the nucleus (blue). Panel B shows the incubation of
cells with all-trans retinoic acid 1 mmol/L for 0, 3, 6, 12, or 24 hours. Twenty micrograms of whole-cell lysates was applied to sodium
dodecylsulfate polyacrylamide gel electrophoresis followed by western blotting with anti-AQP3 and antieb-actin antibodies. Panel C shows
the incubation of cells with all-trans retinoic acid 0, 0.01, 0.1, or 1 mmol/L for 24 hours. Levels of AQP3 protein were examined by western
blotting. The results are representative of three independent experiments. The expression of AQP3 was dose-dependently increased by all-
trans retinoic acid treatment. *P < 0.05 vs untreated control. AQP3 ¼ aquaporin 3; Con ¼ control; GAPDH ¼ glyceraldehyde 3-phosphate
dehydrogenase.
ATRA Increases AQP3 in Vaginal Epithelial Cells e251ATRA Increases AQP3 Protein Expression in
CRL2616 Cells
To investigate whether ATRA affected the expression of
AQP3 in human vaginal mucosal epithelial cells, CRL2616 cells
were treated with ATRA 1 mmol/L for 0, 3, 6, 12, and 24 hours
and AQP3 protein in whole-cell lysates was measured by western
blot analysis. The expression of AQP3 increased with time,
signiﬁcantly so after 12 to 24 hours (Figure 1B). To examine the
dose-dependent effect of ATRA, cells were treated with ATRA 0,
0.01, 0.1, and 1 mmol/L for 24 hours. ATRA increased AQP3
protein levels in a concentration-dependent manner (Figure 1C).ATRA Upregulates AQP3 mRNA Expression in
CRL2616 Cells
To analyze the effect of ATRA on the expression of AQP3
mRNA in CRL2616 cells, cells were treated with ATRA 0.01,
0.1, and 1 mmol/L for 24 hours. Similar to the AQP3 protein
expression, the AQP3 mRNA expression level increased in
a concentration-dependent manner after ATRA treatment
(Figure 2).ATRA Increases AQP3 Expression in CRL2616 Cells
Through RAR
The effects of ATRA are mediated by its receptors, and ATRA
regulates the expression of its own receptors. We examined the
expression of RAR isoforms in response to ATRA treatment.Sex Med 2016;4:e249ee254Treatment of ATRA increased the expression of RARa in cells
(Figure 3).
The effects of ATRA on AQP 3 expression were investigated
further using an antagonist to the RAR. The antagonist (Ro 41-
5253) is a synthetic retinoid that binds RARa (high afﬁnity),
RARb, and RARg (low afﬁnity) and subsequently blocks bind-
ing of ATRA. Treatment of CRL2616 cells with the RAR
antagonist for 24 hours signiﬁcantly decreased AQP3 protein
expression compared with controls, which suggested that the
effects of ATRA on the expression of AQP3 were dependent on
RAR (Figure 4).DISCUSSION
In the present study, ATRA signiﬁcantly increased the levels of
AQP3 protein in vaginal mucosal epithelial cells. Furthermore, as
shown by reverse transcription polymerase chain reaction, ATRA
increased the levels of AQP3 mRNA in a dose-dependent
manner. To our knowledge, this study is the ﬁrst to report a
possible relation between AQP3 and ATRA in the regulation of
the vaginal lubrication mechanism.
The female genital arousal response is a complex physiologic
process. Although the vagina does not have any gland structure,
it secretes large amounts of vaginal ﬂuid that plays an impor-
tant role in vaginal lubrication.18 Human vaginal ﬂuid is
a complex biological ﬂuid composed of water, electrolytes,
Figure 2. Effects of all-trans retinoic acid on AQP3 expression
analyzed by reverse transcription polymerase chain reaction.
CRL2616 cells were incubated with all-trans retinoic acid 0.01, 0.1,
or 1 mmol/L for 24 hours. Then, cells were harvested and total RNA
was prepared. All-trans retinoic acid dose-dependently increased
AQP3 gene expression in cultured human vaginal mucosal epithelial
cells. *P < 0.05 vs untreated control. AQP3 ¼ aquaporin 3; Con ¼
control; RA ¼ retinoic acid.
Figure 3. Expression of RARa protein after all-trans retinoic acid
treatment for 24 hours in cultured human vaginal mucosal
epithelial cells. Cells were incubated with all-trans retinoic acid 0.01,
0.1, or 1 mmol/L for 24 hours and levels of RARa protein were
examined by western blotting with anti-RARa and antieb-actin.
There was a signiﬁcant increase in the expression of RARa at
the all-trans retinoic acid doses of 0.1 and 1 mmol/L. Results
are representative of three independent experiments. *P < 0.05 vs
untreated control. Con ¼ control; RA ¼ retinoic acid; RARa ¼
retinoic acid receptor-a.
e252 Lee et allow-molecular-weight organic compounds (glucose, lipids, and
amino acid), cells (epithelial cells, leukocytes, and lympho-
cytes), and some proteins and enzymes.19 The subepithelial
region of the vaginal wall includes a compact and rich micro-
vascular network of capillaries that are an important compo-
nent of vaginal lubrication.5 The vaginal epithelium, in the
basal state, reabsorbs sodium as plasma transudates from the
capillaries located in the submucosal area. Levin20 suggested
that the vaginal epithelium can transport Naþ ions from the
vascular lumen to the serosal tissues, which could mediate the
formation of vaginal ﬂuid. Until now, however, the exact
mechanism of vaginal lubrication has not been fully disclosed.
It remains unclear whether vaginal lubrication is mediated
mainly by blood ﬂow or whether other potential mechanisms
independent of blood ﬂow also contribute.18
AQPs have been suggested to play an important role in
vaginal lubrication.9 In our previous animal study, we suggested
a role for AQPs in vaginal lubrication by demonstrating the
expression of AQP1, 2, and 3 in rat vagina.9,21 We suggested
that sexual stimulation by electric stimulation of the pelvic
nerve might be involved in moving the AQP channel from the
cytoplasm to the cell membrane of the epithelium and that this
alteration might induce water transport across the vaginal cells.
In our follow-up human study, we reported the distinct pres-
ence and immuno-localization of AQP1, 2, 3, 5, and 6 inhuman vaginal tissue from premenopausal women.10 In that
study, we showed that AQP water channels have different
cellular localization and suggested that the AQPs might have
different functional roles depending on their subtypes and
cellular location.
At least 13 AQPs (AQP0e12) have been identiﬁed to date in
mammalian cells, all of which are highly permeable to water. Of
these, AQP3, 7, 9, and 10 also are permeable to glycerol and
some solutes and are called aquaglyceroporins.2 Evidence from
many studies in humans and mice lacking AQPs indicates that
AQPs have important physiologic roles, including facilitating
trans-epithelial water transport, skin hydration, and urine con-
centration and regulating glandular secretion.22,23
In the human skin, Bellemère et al17 investigated whether
ATRA, a potent modulator of keratinocyte proliferation and
differentiation, could regulate AQP3 expression in human
epidermal keratinocytes. They reported that topical application
of ATRA resulted in signiﬁcant changes in the epidermal
expression of AQP3 and powerful immunoreactivity in the
epidermal layers of the skin in vivo and in vitro. They also found
that the increased expression of AQP3 gene and protein inducedSex Med 2016;4:e249ee254
Figure 4. Expression of AQP3 after treatment with a retinoic
acid receptor antagonist (Ro 41-5253). CRL2616 cells were treated
with all-trans retinoic acid 1 mmol/L and different amounts of Ro
41-5253 for 24 hours. Whole-cell lysates were applied to sodium
dodecylsulfate polyacrylamide gel electrophoresis followed by
western blotting with anti-AQP3 and antieb-actin antibodies.
Treatment of human vaginal mucosal cells with Ro 41-5253 for
24 hours signiﬁcantly decreased AQP3 protein expression
compared with controls. Results represent at least three indepen-
dent experiments. *P < 0.05 vs untreated control. AQP3 ¼
aquaporin 3.
ATRA Increases AQP3 in Vaginal Epithelial Cells e253by ATRA was associated with increased glycerol uptake in
human epidermal keratinocytes.17
Considering the characteristics of mucoid vaginal ﬂuid,
aquaglyceroporins are likely to be involved in the vaginal lubri-
cation mechanism. In the present study, therefore, we focused on
AQP3 because it is an aquaglyceroporin that transports glycerol
and possibly other small solutes in addition to water.
ATRA is a potent stimulator of keratinocyte proliferation in
skin and is usually prescribed for various skin diseases to enhance
skin hydration.24 ATRA also is involved in vaginal epithelial
differentiation and proliferation. For example, ATRA deﬁciency
in rodents results in a persistent keratinization response of the
vaginal epithelium.25 In the epithelial lining of the reproductive
tracts, including the vagina, cervix, and uterus, a speciﬁc role for
ATRA has been suggested in epithelial proliferation and in
alteration of the pattern of keratinization.26 The induction of
gene transcription by ATRA is mediated by the ATRA receptor
(RAR).27,28 In the present study, we found that the increase in
AQP3 protein stimulated by ATRA was correlated with an in-
crease in the ATRA receptor (RARa), which suggests the activeSex Med 2016;4:e249ee254involvement of RARa in mediating the interaction between
AQP3 and ATRA across the vaginal epithelial cells. To conﬁrm
the involvement of RAR, we examined the effect of RAR
antagonist on the expression of AQP3 and found a signiﬁcant
dose-dependent decrease in AQP3 expression. These results
suggest that the effect of ATRA on AQP3 expression actively
involves RAR in a dose-dependent manner. In this study, we
used an RAR antagonist (Ro 41-5253) that binds RARa (high
afﬁnity), RARb, and RARg (low afﬁnity) and subsequently
blocks binding of ATRA. Further studies are needed to evaluate
the role of RAR subtypes on AQP3 expression using small
interfering RNA methods.
To our knowledge, this study is the ﬁrst to report a possible
relation between AQP3 and ATRA in the regulation of the
vaginal lubrication mechanism. Modiﬁcation of AQP3 by ATRA
in human vaginal epithelial cells is a new action among the
numerous established effects of ATRA.
Other experimental methods for studying the actual vaginal
ﬂuid in vivo might yield further insight into the mechanism of
vaginal lubrication. In our next study, we plan to study the
molecular signal transduction pathway involved in the expression
of AQPs with ATRA stimulation and determine whether regu-
lating the expression of AQPs in vaginal tissue might improve
vaginal lubrication in an animal model. We presume that a
knockout animal model would help facilitate this investigation of
the relation of these two molecules in the vaginal lubrication
process. Further investigation into the effects of ATRA-induced
AQP3 expression and water permeability in vivo or in vitro ul-
timately could provide a novel approach for elucidating the
pathophysiology of vaginal secretion and for treating the sexual
dysfunction of diminished vaginal lubrication. Additional studies
are needed to investigate the regulation of all kinds of AQPs by
ATRA with the use of vaginal cells in various clinical conditions.
This goal might be accomplished by targeting speciﬁc disease
conditions, such as dyspareunia, vaginal dryness, and sexual pain
disorder, that might be affected by an abnormal sexual response
and vaginal lubrication. Thus, the results of the present study
have potential implications for future therapeutic options for the
treatment of female sexual dysfunctions and abnormal vaginal
lubrication.
CONCLUSIONS
The present results showed that ATRA mediated by RAR
increased the expression of the AQP3 gene and protein in human
vaginal mucosal epithelial cells. These results imply that AQP3
regulated by ATRA could play an important role in the mech-
anism of vaginal lubrication.Corresponding Author: Kwangsung Park, MD, PhD,
Department of Urology, Chonnam National University Medical
School, 8 Hakdong, Donggu, Gwangju 501-757, Republic of
Korea. Tel: þ82-62-220-6701; Fax: þ82-62-227-1643; E-mail:
uropark@gmail.com
e254 Lee et alConﬂict of Interest: The authors report no conﬂicts of interest.
Funding: This study was supported by a grant (CRI12056-21)
Chonnam National University Hospital Biomedical Research
Institute.STATEMENT OF AUTHORSHIP
Category 1
(a) Conception and Design
Kwangsung Park(b) Acquisition of Data
Hyun-Suk Lee; Sun-Ouck Kim(c) Analysis and Interpretation of Data
Hyun-Suk Lee; Sun-Ouck Kim; Kyuyoun Ahn; Kwangsung ParkCategory 2
(a) Drafting the Article
Hyun-Suk Lee; Sun-Ouck Kim; Kwangsung Park(b) Revising It for Intellectual Content
Kyuyoun Ahn; Kwangsung ParkCategory 3
(a) Final Approval of the Completed Article
Hyun-Suk Lee; Sun-Ouck Kim; Kyuyoun Ahn; Kwangsung ParkREFERENCES
1. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the
United States: prevalence and predictors. JAMA 1999;
281:537-544.
2. Goldstein I, Berman JR. Vasculogenic female sexual
dysfunction: vaginal engorgement and clitoral erectile insuf-
ﬁciency syndromes. Int J Impot Res 1998;10(Suppl. 2):
S84-S90.
3. Gruenwald I, Lowenstein L, Gartman I, et al. Physiological
changes in female genital sensation during sexual stimulation.
J Sex Med 2007;4:390-394.
4. Jannini EA, Buisson O, Rubio-Casillas A. Beyond the G-spot:
clitourethrovaginal complex anatomy in female orgasm. Nat
Rev Urol 2014;11:531-538.
5. Shabsigh A, Buttyan R, Burchardt T, et al. The microvascular
architecture of the rat vagina revealed by image analysis of
vascular corrosion casts. Int J Impot Res 1999;11(Suppl.):
S23-S30.
6. Verkman AS. More than just water channels: unexpected
cellular roles of aquaporins. J Cell Sci 2005;118:3225-3235.
7. Agre P, King LS, Yasui M, et al. Aquaporin water channels-
from atomic structure to clinical medicine. J Physiol 2002;
542:3-16.
8. Yasui M. Molecular mechanisms and drug development in
aquaporin water channel diseases: structure and function of
aquaporins. J Pharmacol Sci 2004;96:260-263.
9. Park K, Han HJ, Kim SW, et al. Expression of aquaporin water
channels in rat vagina: potential role in vaginal lubrication.
J Sex Med 2008;5:77-82.10. Kim SO, Oh KJ, Lee HS, et al. Expression of aquaporin water
channels in the vagina in premenopausal women. J Sex Med
2011;8:1925-1930.
11. Ahuja HS, Szanto A, Nagy L, et al. The retinoid X receptor and
its ligands: versatile regulators of metabolic function, cell dif-
ferentiation and cell death. J Biol Regul Homeost Agents
2003;17:29-45.
12. Wilson L, Gale E, Maden M. The role of retinoic acid in the
morphogenesis of the neural tube. J Anat 2003;203:357-368.
13. Zhou X, Kong N, Wang J, et al. Cutting edge: all-trans retinoic
acid sustains the stability and function of natural regulatory T
cells in an inﬂammatory milieu. J Immunol 2010;185:2675-
2679.
14. Fawzi WW, Herrera MG, Willett WC, et al. Dietary vitamin A
intake and the incidence of diarrhea and respiratory infection
among Sudanese children. J Nutr 1995;125:1211-1221.
15. Ross AC, Stephensen CB. Vitamin A and retinoids in antiviral
responses. FASEB J 1996;10:979-985.
16. Ross DA. Vitamin A and public health: challenges for the next
decade. Proc Nutr Soc 1998;57:159-165.
17. Bellemère G, Von Stetten O, Oddos T. Retinoic acid increases
aquaporin 3 expression in normal human skin. J Invest Der-
matol 2008;128:542-548.
18. Traish AM, Botchevar E, Kim NN. Biochemical factors modu-
lating female genital sexual arousal physiology. J Sex Med
2010;7:2925-2946.
19. Dasari S, Pereira L, Reddy AP, et al. Comprehensive proteomic
analysis of human cervical vaginal ﬂuid. J Proteome Res
2007;6:1258-1268.
20. Levin RJ. Actions of spermicidal and virucidal agents on
electrogenic ion transfer across human vaginal epithelium
in vitro. Pharmacol Toxicol 1997;81:219-225.
21. Kim SO, Lee HS, Ahn K, et al. Effect of estrogen deprivation
on the expression of aquaporins and nitric oxide synthases in
rat vagina. J Sex Med 2009;6:1579-1586.
22. Nielsen S, Frokiaer J, Marples D, et al. Aquaporins in the kidney:
from molecules to medicine. Physiol Rev 2002;82:205-244.
23. Verkman AS. Physiological importance of aquaporin water
channels. Ann Med 2002;34:192-200.
24. Smit JV, de Jong EM, van Hooijdonk CA, et al. Systemic
treatment of psoriatic patients with bexarotene decreases
epidermal proliferation and parameters for inﬂammation, and
improves differentiation in lesional skin. J Am Acad Dermatol
2004;51:257-264.
25. Van Wauwe J, Van Nyen G, Coene MC, et al. Liarozole, an
inhibitor of retinoic acid metabolism, exerts retinoid-mimetic
effects in vivo. J Pharmacol Exp Ther 1992;261:773-779.
26. Boehm N, Chateau D, Rochette-Egly C. Retinoid receptors in
rat vaginal and uterine epithelia: changes with ovarian steroids.
Mol Cell Endocrinol 1997;132:101-108.
27. Mangelsdorf DJ, Kliewer SA, Kakizuka A, et al. Retinoid re-
ceptors. Recent Prog Horm Res 1993;48:99-121.
28. Mangelsdorf DJ, Evans RM. The RXR heterodimers and
orphan receptors. Cell 1995;83:841-850.Sex Med 2016;4:e249ee254
